Detalhe da pesquisa
1.
Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay.
Hematol Transfus Cell Ther
; 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307822
2.
Survival Analysis of Newly Diagnosed Multiple Myeloma Patients after Frontline Autologous Stem Cell Transplantation in a Real-Life Setting.
Acta Medica (Hradec Kralove)
; 66(3): 117-121, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511422
3.
Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.
JCO Glob Oncol
; 9: e2300182, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060975
4.
Digital Ischemia as an Unusual Manifestation of Hodgkin's Lymphoma.
Case Rep Hematol
; 2018: 1980749, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30210881
5.
Consenso del Grupo de Estudio Latinoamericano de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de pandemia SARS-CoV-2 / COVID- 19 / Consensus of the Latin American Study Group on Multiple Myeloma (MM) GELAMM for the management of MM in a state of Pandemic SARS-CoV-2 / COVID-19
Rev. colomb. cancerol
; 24(supl.1): 227-240, oct.-dic. 2020. tab, graf
Artigo
em Espanhol
| LILACS | ID: biblio-1251510
6.
Efectividad del tratamiento con bortezomib en pacientes con mieloma múltiple en el Hospital de Clínicas en el período 2009-2016. Montevideo, Uruguay / Effectiveness of bortezomib treatment in patients with multiple myeloma at the Clínicas Hospital between 2009 and 2016. Montevideo, Uruguay
Rev. méd. Urug
; 34(4): 209-216, dic. 2018.
Artigo
em Espanhol
| LILACS | ID: biblio-968106